Announcements Trials
Browse Landscape

Status

No longer available 2

Sponsor Class

INDUSTRY 2

Study Type

Interventional 9Expanded_access 2

Sponsor

Cancer Type

Sarcoma 2Thoracic 1Other solid neoplasm 1Genitourinary 1

Conditions

Sarcoma 2Sarcoma, Synovial 1Rhabdoid Tumor 1Neoplasms 1Mesothelioma, Malignant 1Desmoplastic Small Round Cell Tumor 1Chondrosarcoma 1Carcinoma, Renal Cell 1

Interventions

tazemetostat 2regorafenib 2nirogacestat 2avapritinib 2Trabectedin 2selinexor 1ripretinib 1omburtamab I-131 1olaratumab 1mifamurtide 1glucarpidase 1ganitumab 1fludarabine phosphate 1balstilimab 1anlotinib 1Whole-Body Irradiation 1Tacrolimus 1TH 302 1Sunitinib 1Proton Pump Inhibitors 1Mycophenolic Acid 1Imatinib Mesylate 1Hydrocortisone 1FANG vaccine 1Everolimus 1DOXO-EMCH 1Cytarabine 1Cord Blood Stem Cell Transplantation 1Carboxypeptidases 1Busulfan 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Expanded_access × tazemetostat × Sarcoma × Clear all
NCT04225429 2024-10-01

Tazemetostat Expanded Access Program for Adults With Epithelioid Sarcoma

Ipsen

No longer available
Sarcoma

Neoplasms, Sarcoma

NCT03874455 2024-03-22

Tazemetostat Expanded Access Program for Adults With Solid Tumors

Ipsen

No longer available
GenitourinaryOther solid neoplasmSarcomaThoracic

Mesothelioma, Malignant, Carcinoma, Renal Cell, Chondrosarcoma, Sarcoma, Sarcoma, Synovial, Rhabdoid Tumor, Desmoplastic Small Round Cell Tumor

Data powered by HemOnc (CC BY 4.0) Colophon âš¡